Therefore, a pivotal element of our investigation is the fact that we used tissue samples from CRC patients, ensuring that CEA protein originates in the CRC tumor itself and the detected glycosylations on CEA represent exactly their distribution in CRC patients. This evidence concerns the gene CEACAM5 and neoplasm.